VERRIX
ActiveSummary
VERRIX has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €583,287 and a net result of €164,754. Equity has been growing by about 14% per year since 2018. Its solvency ranks better than 69% of 19,751 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 21-02-2003 Normal situation
- Activity
- Psychology services NACE 86931and 1 other
- Establishment unit
- 2.186.345.257 3384 Glabbeek, since 14-02-2003
- Financial year end
- 31 December
- Peppol
- Reachable since 07-05-2026
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2024
- Gross margin
- €359,138
- ▲ 77.9%
- Turnover
- ≈ €540,000
- estimated
- Profit
- €164,754
- ▲ 33.9%
- Equity
- €583,287
- ▲ 39.4%
- Total assets
- €714,777
- ▲ 42.7%
- 2025 accounts not filed, 95 days past the deadline
Score breakdownraises riskCapped at 59: a confirmed filing finding1 financial year not filed after the legal deadline; last filed accounts filed 61 days late; 2 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 12.65, cash €479,232Equity €583,287 (81.6% of total assets)Show the evidence
Checked score
Score 2024
57
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 78% of micro companies in human health (NACE 86)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2023
Strong
Solvency
100=
equity 81.6% of total assets
Liquidity
100+3
short-term debt 7.6% · cash 67.0%
Profitability
98+19
return on assets 23.0%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025highest value
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €30,000 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity is ample, with a current ratio of 12.65 (6.2 in 2023), above the usual 1.5. Short-term debt is 7.6% and cash 67% of total assets. 18.4% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 58% on profitability and 76% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 95 days later.
NBB · 10 filingsPosition against the passed deadline
31-12-2025 year end31-07-2026 deadline03-11-2026 today
raises risk · 2024 accounts filed 61 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
not filed
2024
61 days late
2023
68 days late
2022
23 days early
2021
61 days late
2020
56 days late
2019
91 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 6 accounts on average 52 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (1)
Financials
Financials · financial year 2024, micro format
2025 annual accounts not yet filed, deadline passed on 31 July 2026 The financial year closed on 31 December 2025. The accounts are due at the latest 7 months after the close (Companies Code art. 3:10). Source: NBB filings, as of 3 November 2026.
Annual accounts 2024 filed on 30-09-2025 PDF all 22 filings
Turnover
≈ €540,000
Estimated: probably between €460,000 and €680,000
Total assets
€714,777▲ 42.7%
2023 · €501,032
Net result
€164,754▲ 33.9%
2023 · €123,029
Working capital
€634,794▲ 60.9%
2023 · €394,646
Multi-year overview
2018 to 2024, 7 financial yearsOperating result
€260,991
▲ 14.6%
2024
20182024
Net result
€164,754
▲ 33.9%
2024
highest quarter of the sector
20182024
Equity
€583,287
▲ 39.4%
2024
highest quarter of the sector
20182024
Total assets
€714,777
▲ 42.7%
2024
highest quarter of the sector
20182024
Debt
€59,490
▼ 27.9%
2024
20182024
Working capital
€634,794
▲ 60.9%
2024
highest quarter of the sector
20182024
Solvency
81.6%
▼ 1.9pp
2024
middle half of the sector
20182024
Current ratio
12.65
▲ 6.46
2024
highest quarter of the sector
20182024
Return on assets (ROA)
23.0%
▼ 1.5pp
2024
middle half of the sector
20182024
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line2018201920202021202220232024
Operating result€89,310-€131,368▲ 47.1%-€62,223€118,109€137,885▲ 16.7%€227,693▲ 65.1%€260,991▲ 14.6%
Net result€60,453-€87,986▲ 45.5%-€76,516below the sector's middle half€76,313within the sector's middle half€55,073within the sector's middle half▼ 27.8%€123,029above the sector's middle half▲ 123%€164,754above the sector's middle half▲ 33.9%
Equity€257,440-€345,427▲ 34.2%€249,291within the sector's middle half▼ 27.8%€307,465within the sector's middle half▲ 23.3%€343,541within the sector's middle half▲ 11.7%€418,533above the sector's middle half▲ 21.8%€583,287above the sector's middle half▲ 39.4%
Total assets€378,079-€483,278▲ 27.8%€508,682within the sector's middle half▲ 5.3%€478,807within the sector's middle half▼ 5.9%€457,888within the sector's middle half▼ 4.4%€501,032within the sector's middle half▲ 9.4%€714,777above the sector's middle half▲ 42.7%
Debt€120,639-€137,851▲ 14.3%€140,750▲ 2.1%€52,701▼ 62.6%€56,056▲ 6.4%€82,500▲ 47.2%€59,490▼ 27.9%
Working capital€97,236-€214,142▲ 120%€251,471above the sector's middle half▲ 17.4%€286,673above the sector's middle half▲ 14.0%€279,072above the sector's middle half▼ 2.7%€394,646above the sector's middle half▲ 41.4%€634,794above the sector's middle half▲ 60.9%
Solvency68.1%-71.5%▲ 3.4pp49.0%within the sector's middle half▼ 22.5pp64.2%within the sector's middle half▲ 15.2pp75.0%within the sector's middle half▲ 10.8pp83.5%within the sector's middle half▲ 8.5pp81.6%within the sector's middle half▼ 1.9pp
Current ratio1.87-2.65▲ 0.782.90within the sector's middle half▲ 0.257.30above the sector's middle half▲ 4.396.53above the sector's middle half▼ 0.766.20within the sector's middle half▼ 0.3312.65above the sector's middle half▲ 6.46
Return on assets (ROA)16.0%-18.2%▲ 2.2pp-15.0%below the sector's middle half▼ 33.2pp15.9%within the sector's middle half▲ 31.0pp12.0%within the sector's middle half▼ 3.9pp24.6%within the sector's middle half▲ 12.5pp23.0%within the sector's middle half▼ 1.5pp
above
within
below
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
The operating result for 2024 is 15% higher than in 2023 and the highest since 2020. It is the fourth rise in a row.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €714,777
Fixed assets
€25,516 ▼ 16.3%
Current assets
€689,261 ▲ 46.5%
Equity and liabilities €714,777
Equity
€583,287 ▲ 39.4%
Provisions
€72,000
Debt
€59,490 ▼ 27.9%
Debt's share of the balance-sheet total falls from 16.5% to 8.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€274,614▲
2023 · €256,914
Cash flow
€178,378▲
2023 · €152,251
Debt to equity
0.10▼
2023 · 0.20
ROE
28.2%▼
2023 · 29.4%
Interest coverage
over 100▲
2023 · 3.57
Debt ≤ 1 year
€54,467▼
2023 · €75,902
Income taxes
€97,982▲
2023 · €32,919
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Investments
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Tangible fixed assets | €50,010 | €9,535 | €1,553 | €8,656 |
| Financial fixed assets | - | €1,000 | - | - |
| Depreciation and write-downs of the year | €27,100 | €28,772 | €29,221 | €13,624 |
Source: notes to the 2021 to 2024 annual accounts (statement of fixed assets)
Subsidies and aid
Flemish government
2022 · 1 entry · €30 awarded · €30 paidAnnual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €38,481 | €33,189 | €25,783 | €27,100 | €28,772 | €29,221 | €13,624 | ▼ 53.4% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | - | - | -€60,349 | -€58,292 | €72,000 | - |
| Other operating charges640/8 | - | - | - | €4,189 | €2,212 | €3,005 | €1,524 | ▼ 49.3% |
| Non-recurring operating charges66A | - | - | - | - | - | €229 | €11,000 | ▲ 48× |
| Gross operating margin9900 | €130,598 | €167,246 | €84,138 | €149,399 | €108,520 | €201,856 | €359,138 | ▲ 77.9% |
| Operating profit (loss)9901 | €89,310 | €131,368 | -€62,223 | €118,109 | €137,885 | €227,693 | €260,991 | ▲ 14.6% |
| Financial income75/76B | - | - | - | €231 | €131 | €245 | €2,108 | ▲ 762% |
| Recurring financial income75 | €256 | €290 | €1,250 | €231 | €131 | €245 | €2,108 | ▲ 762% |
| Financial charges65/66B | - | - | - | €2,558 | €75,933 | €71,989 | €363 | ▼ 99.5% |
| Recurring financial charges65 | €4,321 | €4,006 | €3,587 | €2,558 | €75,933 | €71,989 | €363 | ▼ 99.5% |
| Profit (loss) for the period before taxes9903 | €85,245 | €127,652 | -€64,560 | €115,783 | €62,083 | €155,949 | €262,736 | ▲ 68.5% |
| Income taxes67/77 | €24,792 | €39,665 | €11,955 | €39,470 | €7,010 | €32,919 | €97,982 | ▲ 198% |
| Profit (loss) for the period9904 | €60,453 | €87,986 | -€76,516 | €76,313 | €55,073 | €123,029 | €164,754 | ▲ 33.9% |
| Transfer from tax-exempt reserves789 | - | - | - | €45,042 | - | €44 | - | - |
| Profit (loss) for the period to be appropriated9905 | €60,437 | €87,973 | -€65,197 | €121,355 | €55,073 | €123,074 | €164,754 | ▲ 33.9% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €378,079 | €483,278 | €508,682 | €478,807 | €457,888 | €501,032 | €714,777 | ▲ 42.7% |
| Fixed assets21/28 | €169,475 | €139,608 | €125,144 | €146,595 | €128,358 | €30,484 | €25,516 | ▼ 16.3% |
| Intangible fixed assets21 | €26,400 | €13,200 | €4,400 | - | - | - | - | - |
| Tangible fixed assets22/27 | €141,975 | €125,308 | €119,644 | €145,495 | €126,258 | €28,384 | €23,416 | ▼ 17.5% |
| Land and buildings22 | - | - | - | €94,165 | €80,166 | - | - | - |
| Plant, machinery and equipment23 | - | - | - | - | €2,558 | €1,209 | €310 | ▼ 74.4% |
| Furniture and vehicles24 | - | - | - | €48,576 | €41,289 | €25,440 | €21,656 | ▼ 14.9% |
| Other tangible fixed assets26 | - | - | - | €2,754 | €2,245 | €1,735 | €1,450 | ▼ 16.4% |
| Financial fixed assets28 | €1,100 | €1,100 | €1,100 | €1,100 | €2,100 | €2,100 | €2,100 | = |
| Current assets29/58 | €208,604 | €343,670 | €383,538 | €332,212 | €329,530 | €470,548 | €689,261 | ▲ 46.5% |
| Amounts receivable within one year40/41 | €94,309 | €91,226 | €94,418 | €85,815 | €86,651 | €195,122 | €198,779 | ▲ 1.9% |
| Trade receivables40 | - | - | - | €85,815 | €86,651 | €106,922 | €121,073 | ▲ 13.2% |
| Other amounts receivable41 | - | - | - | - | - | €88,200 | €77,706 | ▼ 11.9% |
| Cash at bank and in hand54/58 | €110,731 | €243,947 | €280,371 | €237,379 | €232,222 | €265,574 | €479,232 | ▲ 80.5% |
| Deferred charges and accrued income490/1 | - | - | - | €9,019 | €10,657 | €9,853 | €11,250 | ▲ 14.2% |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €378,079 | €483,278 | €508,682 | €478,807 | €457,888 | €501,032 | €714,777 | ▲ 42.7% |
| Equity10/15 | €257,440 | €345,427 | €249,291 | €307,465 | €343,541 | €418,533 | €583,287 | ▲ 39.4% |
| Contributions10/11 | €6,200 | €6,200 | - | €6,200 | €6,200 | €18,600 | €18,600 | = |
| Reserves13 | €209,285 | €297,272 | €266,333 | €301,265 | €337,341 | €399,933 | €564,687 | ▲ 41.2% |
| Non-distributable reserves130/1 | - | - | - | €1,860 | €1,860 | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €1,860 | €1,860 | - | - | - |
| Tax-exempt reserves132 | - | - | - | €44 | €44 | - | - | - |
| Distributable reserves133 | - | - | - | €299,361 | €335,436 | €399,933 | €564,687 | ▲ 41.2% |
| Profit (loss) carried forward14 | €41,955 | €41,955 | -€23,242 | - | - | - | - | - |
| Provisions and deferred taxes16 | - | - | €118,641 | €118,641 | €58,292 | - | €72,000 | - |
| Provisions for liabilities and charges160/5 | - | - | - | €118,641 | €58,292 | - | €72,000 | - |
| Other liabilities and charges164/5 | - | - | - | €118,641 | €58,292 | - | €72,000 | - |
| Amounts payable17/49 | €120,639 | €137,851 | €140,750 | €52,701 | €56,056 | €82,500 | €59,490 | ▼ 27.9% |
| Amounts payable within one year42/48 | €111,368 | €129,528 | €132,067 | €45,539 | €50,459 | €75,902 | €54,467 | ▼ 28.2% |
| Trade debts44 | €173 | €608 | €1,327 | €529 | €2,532 | €6,564 | €6,313 | ▼ 3.8% |
| Suppliers440/4 | - | - | - | €529 | €2,532 | €6,564 | €6,313 | ▼ 3.8% |
| Taxes, remuneration and social security45 | - | - | - | €19,939 | €20,845 | €4,612 | €44,730 | ▲ 870% |
| Taxes450/3 | - | - | - | €18,907 | €20,845 | €4,268 | €44,730 | ▲ 948% |
| Remuneration and social security454/9 | - | - | - | €1,032 | - | €344 | - | - |
| Other amounts payable47/48 | - | - | - | €25,071 | €27,082 | €64,726 | €3,424 | ▼ 94.7% |
| Accrued charges and deferred income492/3 | - | - | - | €7,162 | €5,597 | €6,598 | €5,023 | ▼ 23.9% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €60,453 | €87,986 | -€76,516 | €76,313 | €55,073 | €123,029 | €164,754 | ▲ 33.9% |
| + Depreciation and write-downs630 | €38,481 | €33,189 | €25,783 | €27,100 | €28,772 | €29,221 | €13,624 | ▼ 53.4% |
| Operating cash flow (approximation) | €98,934 | €121,176 | -€50,733 | €103,413 | €83,845 | €152,251 | €178,378 | ▲ 17.2% |
| Investment in fixed assets (approximation) | - | -€3,323 | -€11,319 | -€48,551 | -€10,535 | €68,653 | -€8,656 | - |
| Change in cash | - | €133,216 | €36,425 | -€42,993 | -€5,156 | €33,351 | €213,658 | ▲ 541% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 20,136 companies had the same profile as VERRIX has now. Two years later, 95.0% were still going and 0.2% had gone bankrupt.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
95.0%
was still going
4.7%
stopped otherwise
0.2%
went bankrupt
That fits the bankruptcy probability of VERRIX itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,136 companies, not a prediction for VERRIX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Latest 10 of 22 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2024 | micro format | 30-09-2025 | 2025-00516886 | |
| 31-12-2023 | micro format | 07-10-2024 | 2024-00495548 | |
| 31-12-2022 | micro format | 08-07-2023 | 2023-00217211 | |
| 31-12-2021 | micro format | 30-09-2022 | 2022-20454948 | |
| 31-12-2020 | micro format | 25-09-2021 | 2021-68900237 | |
| 31-12-2019 | micro format | 30-10-2020 | 2020-66600571 | |
| 31-12-2018 | micro format | 10-10-2019 | 2019-69900433 | |
| 31-12-2017 | micro format | 11-09-2018 | 2018-63200406 | |
| 31-12-2016 | micro format | 15-09-2017 | 2017-61400265 | |
| 31-12-2015 | abbreviated format | 31-08-2016 | 2016-58300543 |
Board & ownership
Directors
Directors
1 director
Verhille Rik
Current
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Indien er verschillende bestuurders zijn aangesteld, zijn zij ieder afzonderlijk bevoegd (tenzij wordt beslist om een collegiaal…”
deed of 12-01-2024Owners and capital
Shareholders
Stated in the act
act of 12-01-2024 ↗
- VERHILLE Rik Bart René aandeelhouder
- DELOOZ Jessica Marie Charlotte aandeelhouder
Share transfer
act of 12-01-2024 ↗
- DELOOZ Jessica Marie Charlotte to DRS. VERHILLE - DELOOZ 93 shares
Capital transactions
Capital over time
- 12-01-2024 Converted to unavailable equity · €6,200
- 12-01-2024 Converted to unavailable equity · €1,860
- 12-01-2024 Capital conversion · €12,400 · eigen vermogensrekening
Articles of association
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Tenzij anders is overeengekomen kan de overdrager van een niet volgestort aandeel die door de vennootschap of een derde tot volstorting…”
- Share issue ruleThe articles set how and by whom new shares are issued.
- “Aandelen waarop in geld wordt ingeschreven, converteerbare obligaties en inschrijvingsrechten moeten eerst worden aangeboden aan de…”
Articles of association, deed of 12-01-2024 (in Dutch)
Network & group
VERRIX shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of VERRIX. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
2025
30-09
micro format · 61 days late
2024
31-12
Financial
Highest result from 2018 to 2024net €164,754 ▲33.9%
The operating result of €260,991 and the net result of €164,754 are both a record.
31-12
Financial
Liquidity doublescurrent ratio 12.65
The current ratio rises from 6.20 to 12.65. Short-term debt falls from €75,902 to €54,467.
31-12
Financial
Equity above €500,000equity €583,287 ▲39.4%
After 4 profitable years in a row, equity reaches €583,287.
07-10
micro format · 68 days late
12-01
Gazette deed
Company renamed from DRS. VERHILLE - DELOOZ to VERRIXTransfer of 93 shares · Shareholding · Director in office12 points ▸
Gazette deed
Company renamed from DRS. VERHILLE - DELOOZ to VERRIX
Transfer of 93 shares · Shareholding · Director in office12 points ▸
- General meeting, “buitengewone algemene vergadering” (deed in Dutch)
- VERHILLE Rik Bart René is a shareholder
- DELOOZ Jessica Marie Charlotte is a shareholder
- Director in office, VERHILLE Rik Bart René (director)
- Name change, VERRIX
- Purpose change
- Share transfer, DELOOZ Jessica Marie Charlotte → DRS. VERHILLE - DELOOZ
- Amendment of the articles, mentioned 2 times in the deed
- Capital conversion, “statutair onbeschikbare eigenvermogensrekening” (deed in Dutch), mentioned 2 times in the deed
- Capital conversion, “eigen vermogensrekening” (deed in Dutch)
- Reserve release, “geldig voor eventuele toekomstige bijstortingen van het deel van het in het verleden geplaatste kapitaal dat op heden nog niet werd gestort en dat werd geboekt…” (deed in Dutch)
- Power of attorney
2023
08-07
micro format · 23 days before the deadline
2022
30-09
micro format · 61 days late
2021
31-12
Financial
Back to profitnet €76,313
The net result is €76,313, after one loss-making year.
31-12
Financial
Liquidity more than doubledcurrent ratio 7.30
The current ratio rises from 2.90 to 7.30. Short-term debt falls from €132,067 to €45,539.
25-09
micro format · 56 days late
2020
31-12
Financial
Weakest financial yearnet -€76,516
The net result drops to -€76,516, the lowest from 2018 to 2024. It recovers the following year.
Show earlier events
30-10
micro format · 91 days late
2019
10-10
micro format · 71 days late
2018
11-09
micro format · 42 days late
2017
15-09
micro format · 46 days late
2016
31-08
abbreviated format · 31 days late
2003
03-03
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
VERRIX in Dutch
Former name
DRS. VERHILLE - DELOOZ until the act of 12-01-2024
Enterprise number
0479.615.015
LEI code
254900WBZCQW48B12Q39
live in the LEI register
Legal form
Private limited company
Status
Active, normale toestand
Founded
21-02-2003
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 12-01-2024 (in Dutch)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaamse Gewest, Het bestuursorgaan is bevoegd de zetel van de vennootschap binnen België te verplaatsen, voor zover die verplaatsing…”
deed of 12-01-2024 (in Dutch)Registered office and establishments
Registered office
Steenbergestraat 1, 3384 Glabbeek, Belgium
Establishment unit
Steenbergestraat 1B, 3384 Glabbeek since 14-02-2003 · unit number 2.186.345.25786220 Specialist medical practice
E-mail
rik.verhille@telenet.beGlabbeek
Activities
NACEBEL 202586931
Psychology services main activity
86220
Specialist medical practice
Codes under NACEBEL 2008
86904
Human health activities main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 12-01-2024 (in Dutch)
“De uitoefening van de geneeskunde door de artsen-aandeelhouders, meer bepaald van radiologie of medische beeldvorming, in naam en voor…”
Text of the purpose
“De uitoefening van de geneeskunde door de artsen-aandeelhouders, meer bepaald van radiologie of medische beeldvorming, in naam en voor rekening van de vennootschap, met inachtname van de regels van de geneeskundige plichtenleer en deontologie in het algemeen en van het beroepsgeheim in het bijzonder”
Invoicing and payment
VAT number
BE 0479.615.015
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Saturday of June at 20:00
deed of 12-01-2024 (in Dutch)Sites & property
Location
Buildings and parcels at the addresses
Ground area
2,830 m²
Building footprint
367 m²
Building volume
2,171 m³
Tallest building: 8.6 m.
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 24004B0142/00L000 | Flanders | 1,872 m² | 1 · 188 m² | 8.5 m · 2 |
| 24004B0121/00F000 | Flanders | 958 m² | 1 · 179 m² | 8.6 m · 2 |